European public procurement and grants data from official registers · Data as of 18 November 2026; updated daily.

Market report

Oncology drug tenders in Portugal — market report, March 2025

Oncology drug tenders in Portugal in March 2025: 1,431 tenders published (+54% month on month, +186% year on year), estimated at €906,609 in total, and 1,418 contracts awarded (+24% month on month, +180% year on year), worth €57,801,485 (awarded value). Buyers with the most tenders: Unidade Local de Saúde do Alto Alentejo, E. P. E. (113), Unidade Local de Saúde de Lisboa Ocidental, E. P. E. (70) and Unidade Local de Saúde de Santa Maria, E. P. E. (66); most contracts won: Generis – Farmaceutica, S.A. (81), Hikma Farmacêutica (Portugal) Sa. (59) and Janssen Cilag Farmaceutica, Lda. (54). On average 19.7 bids per contract; 11% of contracts had a single bid. Report made on 27 October 2026.

Tenders published
1,431
Contracts awarded
1,418
Contract value awarded
€57,801,485
Bids per contract
19.7
Tenders published per month
05001K1.5KMar 24: 500Mar 24: 500Mar 24Apr 24: 492Apr 24: 492Apr 24May 24: 92May 24: 92May 24Jun 24: 136Jun 24: 136Jun 24Jul 24: 143Jul 24: 143Jul 24Aug 24: 62Aug 24: 62Aug 24Sep 24: 294Sep 24: 294Sep 24Oct 24: 241Oct 24: 241Oct 24Nov 24: 230Nov 24: 230Nov 24Dec 24: 967Dec 24: 967Dec 24Jan 25: 1,160Jan 25: 1,160Jan 25Feb 25: 931Feb 25: 931Feb 25Mar 25: 1,431Mar 25: 1,4311,431Mar 25
Contracts awarded per month
05001K1.5KMar 24: 507Mar 24: 507Mar 24Apr 24: 435Apr 24: 435Apr 24May 24: 65May 24: 65May 24Jun 24: 86Jun 24: 86Jun 24Jul 24: 95Jul 24: 95Jul 24Aug 24: 78Aug 24: 78Aug 24Sep 24: 253Sep 24: 253Sep 24Oct 24: 199Oct 24: 199Oct 24Nov 24: 386Nov 24: 386Nov 24Dec 24: 1,212Dec 24: 1,212Dec 24Jan 25: 1,017Jan 25: 1,017Jan 25Feb 25: 1,143Feb 25: 1,143Feb 25Mar 25: 1,418Mar 25: 1,4181,418Mar 25

The highlighted bar is March 2025. Hover a bar for its figure; the table below has every value.

FigureMarch 2025February 2025ChangeMarch 2024Change
Tenders published1,431931+54%500+186%
Estimated value€906,609€3,610,860-75%——
Buyers3234-6%31+3%
Contracts awarded1,4181,143+24%507+180%
Contract value (awarded)€57,801,485€11,299,843+412%€8,409,649+587%
Winners7468+9%44+68%
Bids per contract19.714.3—13.3—
Single-bid contracts11%4%—16%—

Buyers with the most tenders

Companies with the most contracts

Where the tenders were

  • Grande Lisboa 1

Procedures

  • not stated 1,429
  • Open procedure 1
  • Restricted procedure 1

Download the figures (CSV)

The report's aggregates: the figures, the comparisons and the top lists by name and count.

All reports: Oncology and immunomodulating drugs

Questions and answers

How many oncology drug tenders were published in Portugal in March 2025?
1,431 (by 32 buyers); for comparison, February 2025: 931, March 2024: 500.
Who won the most oncology drug tenders in Portugal in March 2025?
By number of contracts: Generis – Farmaceutica, S.A. (81), Hikma Farmacêutica (Portugal) Sa. (59), Janssen Cilag Farmaceutica, Lda. (54), Teva Pharma - Produtos Farmaceuticos,lda (54) and Labesfal-Lab. Almiro, Sa. (53); 74 companies won contracts in all.
Which buyers published the most oncology drug tenders in March 2025?
Unidade Local de Saúde do Alto Alentejo, E. P. E. (113), Unidade Local de Saúde de Lisboa Ocidental, E. P. E. (70), Unidade Local de Saúde de Santa Maria, E. P. E. (66), Unidade Local de Saúde do Arco Ribeirinho, E.P.E. (63) and Unidade Local de Saúde de Entre O Douro e Vouga, E.P.E (61).
How competitive were oncology drug tenders in Portugal in March 2025?
On average 19.7 bids per contract (901 contracts with a known number of bids); 11% of contracts had a single bid.
What were the contracts worth in March 2025?
€57,801,485 (awarded value, 1,418 contracts); median about €370,000.

How the report is made

Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.